Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination

Journal of Clinical Psychopharmacology

Volumn 28, Issue 6, 2008, Pages 723-725

  Coskun, Murat ^a   Zoroglu, Salih ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; METHYLPHENIDATE; MIRTAZAPINE; CENTRAL STIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; ANGER; ANOREXIA; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; BEHAVIOR DISORDER; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFECT; DRUG FORMULATION; DRUG WITHDRAWAL; EXTENDED RELEASE FORMULATION; HALLUCINATION; HUMAN; HYPERACTIVITY; IRRITABILITY; LETTER; MALE; MORNING DOSAGE; PRIORITY JOURNAL; SCHOOL CHILD; SEPARATION ANXIETY; SLEEP DISORDER; SYMPTOM; TACTILE HALLUCINATION; VISUAL HALLUCINATION; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; PSYCHOLOGICAL ASPECT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOPAMINE UPTAKE INHIBITORS; DRUG COMBINATIONS; FLUOXETINE; HALLUCINATIONS; HUMANS; MALE; METHYLPHENIDATE; SEROTONIN UPTAKE INHIBITORS;

EID: 59049107309     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31818ce752     Document Type: Letter

References (11)

1. Rashid J, Mitelman S. Methylphenidate and somatic hallucinations, J Am Acad Child Adolesc Psychiatry. 2007;46(8):945-946.
2. Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr. 1981; 2:35-38.
3. Ross R. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2006; 163(7):1149-1152.
4. Omar SJ, Robinson D, Davies HD, et al. Fluoxetine and visual hallucinations in dementia. Biol Psychiatry. 1995;38(8):556-558.
5. Webb A. Fluoxetine induced auditory hallucinations in an adolescent, J Paediatr Child Health. 2003;39:637-639.
6. Abali O, Mukaddes NM. Methylphenidate induced hallucinations: case report [in Turkish]. Bull Clin Psychopharmacol. 2007;17: 195-197.
7. Bourgeois JA, Thomas D, Johansen T, et al. Visual hallucinations associated with fluoxetine and sertraline. J Clin Psychopharmacol. 1998;18(6):482-483.
8. Achamallah NS. Visual hallucinations after combining fluoxetine and dextromethorphan. Am J Psychiatry. 1992;149(10):1406.
9. Findling R. Open-label treatment of comorbid depression and attentional disorder with co- administration of SRI's and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol. 1996;6:165-175.
10. Gammon KD, Nolan EE, Sverd J, et al. Methylphenidate in combination for treatment of attention-deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol. 1993;3:1-10.
11. Lauterbach EC. Dopaminergic hallucinosis with fluoxetine in Parkinson's disease. Am J Psychiatry. 1993;150(11):1750.